Association Between Sacubitril/Valsartan Initiation and Health Status Outcomes in Heart Failure With Reduced Ejection Fraction-Reference-Cited by-同舟云学术

Association Between Sacubitril/Valsartan Initiation and Health Status Outcomes in Heart Failure With Reduced Ejection Fraction

Published:2019-11 Issue:11 Volume:7 Page:933-941
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

Khariton Yevgeniy,Fonarow Gregg C.,Arnold Suzanne V.,Hellkamp Ann,Nassif Michael E.,Sharma Puza P.,Butler Javed,Thomas Laine,Duffy Carol I.,DeVore Adam D.,Albert Nancy M.,Patterson J. Herbert,Williams Fredonia B.,McCague Kevin,Spertus John A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines;Yancy;J Am Coll Cardiol,2013

2. Cardiovascular health: the importance of measuring patient-reported health status: a scientific statement from the American Heart Association;Rumsfeld;Circulation,2013

3. Association of serial Kansas City Cardiomyopathy Questionnaire assessments with death and hospitalization in patients with heart failure with preserved and reduced ejection fraction: a secondary analysis of 2 randomized clinical trials;Pokharel;JAMA Cardiol,2017

4. Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments;Kosiborod;Circulation,2007

5. Prognostic value of health status in patients with heart failure after acute myocardial infarction;Soto;Circulation,2004

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving Utilization of Guideline-Directed Medical Therapy for Heart Failure;The Journal for Nurse Practitioners;2024-09

2. 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction;Journal of the American College of Cardiology;2024-04

3. Contemporary pharmacological treatment and management of heart failure;Nature Reviews Cardiology;2024-03-26

4. Sacubitril/Valsartan in the primary treatment of heart failure with reduced ejection fraction (HFrEF);Die Kardiologie;2023-10-20

5. Nonresponse to Heart Failure Therapy;JACC: Heart Failure;2023-06